Abstract: The present invention relates to sulphonic acids of ditolylether sulphones of formula I ##STR1## in which n is 0 to 6, each of x and y, independently, is 0 or 1 with the proviso that x+y is at least one, or salts thereof and condensates of the same with formaldehyde, which compounds are useful, inter alia, as dispersing agents for disperse dyestuff preparations.

Abstract: A non-chromophoric conjugated derivative of 7-styryl coumarin for use as an optical brightener in which the lactone ring of the coumarinyl group may have a benzene ring fused to it to form a 3,4-benzocoumarinyl-7 group, the phenyl group of the styryl is substituted by a conjugated group which contains a group derived from an acid in its conjugation and which group is so located as to conjugate with the ethylene group.

Abstract: Novel cyclosporins having an -Allylgly- residue in the 2-position and/or a -(D)-Ser- residue in the 8-position and process for their production. The novel cyclosporins are useful as pharmaceuticals, e.g. as immunosuppressive and anti-inflammatory agents.

Abstract: Microspheres, prepared by solvent removal from an oil-in-water emulsion using carboxylic acid salt surfactant, e.g., sodium oleate as the emulsifier.

Abstract: Compounds of the formula ##STR1## in which A is the radical of a sulpho group-containing diazo component of the aniline or 1- or 2-aminonaphthalene series,K is a coupling component radical of the phenol series, having a free hydroxy group or an etherified or acylated hydroxy group,R.sub.1 is hydrogen C.sub.1-4 alkoxy, C.sub.1-4 alkyl or C.sub.1-4 haloalkyl,R.sub.2 is C.sub.1-4 alkyl, C.sub.1-6 alkyl-CO-, C.sub.1-6 alkyl-O-CO-, -CONH.sub.2, C.sub.1-6 alkyl-NH-CO-, di-(C.sub.1-6 alkyl)N-CO-, 2-, 3-, 4-, 5- or 6-hydroxy(C.sub.2-6 alkyl)-NH-CO- or (2-, 3-, 4-, 5- or 6-hydroxy(C.sub.2-6 alkyl)).sub.2 N-CO-, andR.sub.10 is hydrogen or C.sub.1-4 alkyl,and mixtures thereof, which compounds are in free acid or salt form and are useful for dyeing or printing anionic dyeable substrates such as leather, natural and synthetic polyamides, polyurethanes and polyolefins modified to contain basic groups, especially nylon.

Abstract: Cyclopropanyl-group-bearing-amides, eg N-[1-(benzyl)-2-(phenyl)ethyl]-cis-2-octyl-cyclopropanoctanamide and N-(.alpha.-methyl-benzyl)-(cis)-2-octyl-cyclopropanoctanamide, are useful as pharmaceutical agents and are obtainable, eg by reacting a mixed anhydride of a cyclopropanyl-group bearing-long chain carboxylic acid with an appropriate amino compound.

Abstract: Benzopyrane and benzothiopyrane derivatives which possess pharmaceutical in particular anti-mycotic activity.

Abstract: A method for the preparation of 2,4-dinitroaniline from 1-chloro-2,4-dinitrobenzene comprising adding ammonia to melted 1-chloro-2,4-dinitrobenzene in such dosages that the temperature of the mixture does not exceed 120.degree. C. and that the pressure does not exceed 3 bar. 6-halo-2,4-dinitroaniline may be produced from the so formed 2,4-dinitroaniline by neutralizing the suspension containing the 2,4-dinitroaniline with acid to give a pH of from the 6-halo-2,4-dinitroaniline. The 6-halo 2,4-dinitroaniline is useful in the preparation of dyestuffs.

Abstract: This invention provides a new opiate withdrawal use of an guanidine derivative and novel pharmaceutical compositions for such use.

Abstract: Agents for lowering glucose levels in blood having the formula: ##STR1## wherein each R, independently, is hydrogen, C.sub.1-6 alkylcarbonyl or a group of the formula ##STR2## where R.sub.1 is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 -alkoxy, halo or trifluoromethyl, andR.sub.2 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy or halo, with the proviso that when one R is hydrogen, the other R is not hydrogen.

Abstract: Compounds of the formula ##STR1## in which R.sub.1 is C.sub.1-4 alkyl,Hal is halogen,R.sub.2 is ##STR2## --SO.sub.2 C.sub.1-4 alkyl, --SO.sub.2 NR.sub.8 R.sub.9 or --NHCOOR.sub.10,R.sub.3 is hydrogen, C.sub.1-4 alkyl or C.sub.1-4 alkoxy,R.sub.4 is hydrogen or C.sub.1-4 alkyl,R.sub.5 is hydrogen; C.sub.1-4 alkyl; cyclohexyl; cyclohexyl substituted by one to three C.sub.1-4 alkyl groups; phenyl or phenyl substituted by one or two substituents selected from halo, C.sub.1-4 alkyl and C.sub.1-4 alkoxy,R.sub.6 is hydrogen or hydroxy, with the proviso that R.sub.6 is hydrogen when R.sub.2 is --NHCOOR.sub.10,R.sub.7 is hydrogen, C.sub.1-4 alkyl or C.sub.1-4 alkoxy,each of R.sub.8 and R.sub.9, independently, is hydrogen, C.sub.1-4 alkyl, C.sub.2-4 hydroxyalkyl, cyclohexyl; or phenyl or phenyl substituted by one or two substituents selected from halo, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, sulfo and carboxy, with the proviso that not more than one of R.sub.8 and R.sub.9 is cyclohexyl, phenyl or substituted phenyl,R.sub.

Abstract: Disclosed are anthraquinone dyestuffs which, in free acid form, are of formula I, ##STR1## in which R signifies an alkyl radical of 6 to 24 carbon atoms, an unsubstituted cyclohexyl radical or a cyclohexyl radical substituted by one or more substituents selected from halogen atoms and alkyl and alkoxy radicals,R.sub.1 and R.sub.2, independently, each signifies an alkyl radical of 1 to 6 carbon atoms,X signifies --O-- or a direct bond,ring A is unsubstituted or substituted by one or two halogen atoms, hydroxyl groups or C.sub.1-4 alkyl or alkoxy groups,their production and use in the dyeing of anionic dyeable substrates, particularly natural and synthetic polyamide fibers.

Abstract: This disclosure describes compounds of the formula ##STR1## wherein n is 3, 5 or 7, andeach R is lower alkyl having 1 to 4 carbon atoms, or pharmaceutically acceptable acid addition salts thereof, which are useful as anti-diabetic agents in particular glucagon inhibiting agents.

Abstract: Compounds of the formula ##STR1## in which A--X-- is the radical of a diazo component,X-- is ortho to the azo group and is a metallizable substituent or a substituent convertible to a metallizable group,Y is --OH or --NH.sub.2,Z is methyl or carboxy,R is hydrogen, halogen, methyl or sulpho,andB is the radical of a coupling component of the heterocyclic, acyclic active methylene or monocyclic benzene series, which coupling component of the monocyclic benzene series contains an amino and/or hydroxy group which groups may be alkylated or acylated, and--N.dbd.N--B is bound to the 3- or 4-position of ring D,which compounds contain at least one water-solubilizing group,and metal complexes thereof, with the proviso that when the compounds are unmetallized, B is other than amonocyclic benzene coupling component radical. The metal complexes are useful as dyes for the dyeing and printing of anionic dyeable.

Abstract: A 5,10-dihydroimidazo[2,1-b]quinazoline in which at least one ring carbon atom, other than the carbon atom in the 2-position, bears a substituent, or a pharmaceutically acceptable acid addition salt thereof is a useful cardiotonic agent and vasodilator in heart insufficiency and a blood platelet aggregation inhibitor.

Abstract: By the use of a known bacterial .alpha.-amylase having significant activity at pH values above 8.5 and temperatures below 30.degree. C., de-sizing and reactive dyeing by the cold dwell process may be carried out simultaneously on cellulose textile materials. The dyed materials have good color yield and levelness and are not hardened.

Abstract: This invention provides a compression process for the production of suppositories characterized in that the compression step is effected at a temperature at or below +10.degree. C., and in the absence of a binding agent.

Abstract: Compounds of the formula ##STR1## wherein F is the residue of a monoazo or disazo compound,each X is independently --NR.sub.2 --Q--NR.sub.3 R.sub.4 or --NR.sub.2 --Q--N.sup..sym. R.sub.5 R.sub.6 R.sub.7,whereinQ is linear or branched C.sub.2-6 alkylene,R.sub.2 is hydrogen or C.sub.1-4 alkyl,each of R.sub.3, R.sub.4, R.sub.5 and R.sub.6 is independently hydrogen; C.sub.1-6 alkyl; C.sub.2-6 alkyl substituted by hydroxy or cyano; C.sub.1-3 alkyl substituted by phenyl or substituted phenyl having 1 to 3 substituents selected from chloro, C.sub.1-4 alkyl and C.sub.1-4 alkoxy; C.sub.5-6 cycloalkyl or C.sub.5-6 cycloalkyl substituted by 1 to 3 C.sub.1-4 alkyl groups, with the proviso that neither R.sub.5 nor R.sub.6 can be hydrogen, orR.sub.3 and R.sub.4 or R.sub.5 and R.sub.6 taken together and with the nitrogen atom to which they are joined form a 5- or 6-membered ring containing at most one further hetero atom, andR.sub.7 is C.sub.1-4 alkyl or benzyl,each Z.sub.1 is independently --CO--, --SO.sub.

Abstract: Tropyl derivatives of the formula: ##STR1## in which R.sup.1 is (a) phenyl linked through a direct bond, --O--, ##STR2## (in which m=2 or 3); (b) diphenylmethyl; or (c) 10H-phenothiazin-10-yl; (each of which type may be substituted, or unsubstituted); R.sup.2 is --H, --OH, or --O Si (CH.sub.3).sub.3 ; and R.sup.3 is substituted or unsubstituted phenyl, e.g. 4-[3-(4-fluorobenzoyl)-8-azabicyclo [3.2.1]oct-8-yl]-1-(-4-fluorophenyl)-1-butanone, in free base form or pharmaceutically acceptable acid addition salts are useful as pharmaceuticals.

Abstract: A stable ergot alkaloid soft gelatin capsule consisting essentially of a soft gelatin capsule shell and encapsulated therein a liquid center fill solution consisting essentially of a therapeutically effective amount of an ergot alkaloid of the formula ##STR1## wherein R.sub.1 is hydrogen or halogen,R.sub.2 is hydrogen or C.sub.1-4 alkyl,R.sub.3 is isopropyl, sec.-butyl, isobutyl or benzyl,R.sub.4 is methyl, ethyl or isopropyl, and eitherR.sub.5 is hydrogen andR.sub.6 is hydrogen or methoxy orR.sub.5 and R.sub.6 together is an additional bond,or mixtures thereof, dissolved in a pharmaceutically acceptable polar, hydrophilic soft gelatin capsule center fill solvent.